Exoplanet atmospheres

Abstract:

NASA's Spitzer Infrared Spectrometer (IRS) acquired mid-infrared (5–37 μm) disc-averaged spectra of Uranus very near to its equinox in December 2007. A mean spectrum was constructed from observations of multiple central meridian longitudes, spaced equally around the planet, which has provided the opportunity for the most comprehensive globally-averaged characterisation of Uranus' temperature and composition ever obtained (Orton et al., 2014a,b). In this work we analyse the disc-averaged spectra at four separate central meridian longitudes to reveal significant longitudinal variability in thermal emission occurring in Uranus' stratosphere during the 2007 equinox. We detect a variability of up to 15% at wavelengths sensitive to stratospheric methane, ethane and acetylene at the ~0.1-mbar level. The tropospheric hydrogen‑helium continuum and deuterated methane absorption exhibit a negligible variation (less than 2%), constraining the phenomenon to the stratosphere. Building on the forward-modelling analysis of the global average study, we present full optimal estimation inversions (using the NEMESIS retrieval algorithm, Irwin et al., 2008) of the Uranus-2007 spectra at each longitude to distinguish between thermal and compositional variability. We found that the variations can be explained by a temperature change of less than 3 K in the stratosphere. Near-infrared observations from Keck II NIRC2 in December 2007 (Sromovsky et al., 2009; de Pater et al., 2011), and mid-infrared observations from VLT/VISIR in 2009 (Roman et al., 2020), help to localise the potential sources to either large scale uplift or stratospheric wave phenomena.

Abstract:

The COVID-19 pandemic has devastated individuals, families, and institutions throughout the world. Despite the breakneck speed of vaccine development, the human population remains at risk of further devastation. The decision to not become vaccinated, the protracted rollout of available vaccine, vaccine failure, mutational forms of the SARS virus, which may exhibit mounting resistance to our molecular strike at only one form of the viral family, and the rapid ability of the virus(es) to hitch a ride on our global transportation systems, means that we are will likely continue to confront an invisible, yet devastating foe. The enemy targets one of our human physiology’s most important and vulnerable life-preserving body tissues, our broncho-alveolar gas exchange apparatus.
Notwithstanding the fear and the fury of this microbe's potential to raise existential questions across the entire spectrum of human endeavor, the application of an early treatment intervention initiative may represent a crucial tool in our defensive strategy. This strategy is driven by evidence-based medical practice principles, those not likely to become antiquated, given the molecular diversity and mutational evolution of this very clever “world traveler”.